Enthera Pharmaceuticals develops first-in-class biologics for several underserved autoimmune conditions, aiming to preserve and re-establish organ cell function and transform the treatment paradigm for intractable autoimmune diseases
Enthera Pharmaceuticals develops first-in-class biologics for several underserved autoimmune conditions, aiming to preserve and re-establish organ cell function and transform the treatment paradigm for intractable autoimmune diseases.